{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:27:57Z","timestamp":1778696877500,"version":"3.51.4"},"reference-count":76,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:00:00Z","timestamp":1495843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Norrlands Njurf\u00f6rening"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>A progressive chronic kidney disease results in retention of various substances that more or less contribute to dysfunction of various metabolic systems. The accumulated substances are denominated uremic toxins. Although many toxins remain undetected, numerous newly defined toxins participate in the disturbance of food breakdown. In addition, toxic effects may downregulate other pathways, resulting in a reduced ability of free fatty acid breakdown by lipoprotein lipase (LPL) and hepatic lipase (HL). Dialysis may even worsen metabolic functions. For LPL and HL, the use of heparin and low molecular weight heparin as anticoagulation during hemodialysis (HD) initiate a loss of these enzymes from their binding sites and degradation, causing a temporary dysregulation in triglyceride breakdown. This lack of function will cause retention of the triglyceride containing lipids for at least 8 h. In parallel, the breakdown into free fatty acids is limited, as is the energy supply by them. This is repeated thrice a week for a normal HD patient. In addition, dialysis will cause a loss of amino acids and disturb glucose metabolism depending on the dialysates used. The addition of glucose in the dialysate may support oxidation of carbohydrate and the retention of Amadori products and subsequent tissue alterations. To avoid these effects, it seems necessary to further study the effects of anticoagulation in HD, the extent of use of glucose in the dialysate, and the supplementation of amino acids.<\/jats:p>","DOI":"10.3390\/nu9060548","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T04:35:42Z","timestamp":1496118942000},"page":"548","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dialysis Procedures Alter Metabolic Conditions"],"prefix":"10.3390","volume":"9","author":[{"given":"Bernd","family":"Stegmayr","sequence":"first","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Umea University, 90187 Umea, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039139880102401004","article-title":"Uremic toxicity: Present state of the art","volume":"24","author":"Vanholder","year":"2001","journal-title":"Int. J. Artif. Organs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1093\/ndt\/gfh509","article-title":"Proteomics: A novel tool to unravel the patho-physiology of uraemia","volume":"19","author":"Weissinger","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","unstructured":"Lerma, E.V., and Weir, M.R. (2017). Malnutrition and Intradialytic Parenteral Nutrition in End-Stage Kidney Disease Patients. Principles and Practice of Dialysis, Wolters Kluwer. [5th ed.]."},{"key":"ref_7","first-page":"67","article-title":"Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia","volume":"19","author":"Alvestrand","year":"1983","journal-title":"Clin. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_9","unstructured":"Johnson, R.J., Feehally, J., and Floege, J. (2015). Hemodialysis: Outcome and Adequacy. Comprehensive Clinical Nephrology, Elsevier."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/ajkd.2002.36344","article-title":"A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis","volume":"40","author":"Wolfson","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","unstructured":"(1970, January 01). Revaclear Dialyzer Technology. Available online: www.baxter.com."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ajcn\/85.3.695","article-title":"Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite","volume":"85","author":"Carrero","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2010.487","article-title":"Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients","volume":"79","author":"Carrero","year":"2011","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/ndt\/gfw104","article-title":"Dialysis modality and nutritional status are associated with variability of inflammatory markers","volume":"31","author":"Snaedal","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1542-4758.2009.00335.x","article-title":"Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain","volume":"13","author":"Holmberg","year":"2009","journal-title":"Hemodial. Int."},{"key":"ref_18","first-page":"169","article-title":"Taste acuity in patients with chronic renal failure","volume":"45","author":"Fernstrom","year":"1996","journal-title":"Clin. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00109-009-0543-3","article-title":"Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease","volume":"88","author":"Tolle","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/toxins6051505","article-title":"Uremic toxins and lipases in haemodialysis: A process of repeated metabolic starvation","volume":"6","author":"Stegmayr","year":"2014","journal-title":"Toxins"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s40279-015-0394-8","article-title":"The Physiological Regulation of Skeletal Muscle Fatty Acid Supply and Oxidation During Moderate-Intensity Exercise","volume":"45","year":"2015","journal-title":"Sports Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Florens, N., Calzada, C., Lyasko, E., Juillard, L., and Soulage, C.O. (2016). Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins, 8.","DOI":"10.3390\/toxins8120376"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archinte.1970.00310110145026","article-title":"Uremic lipemia. An unrecognized abnormality in triglyceride production and removal","volume":"126","author":"Bagdade","year":"1970","journal-title":"Arch. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.ndt.a027068","article-title":"Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure","volume":"11","author":"Attman","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_25","first-page":"176","article-title":"Hyperlipidemia in renal failure: Studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl","volume":"91","author":"Bagdade","year":"1978","journal-title":"J. Lab. Clin. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1525-139X.2009.00661.x","article-title":"Causes of dysregulation of lipid metabolism in chronic renal failure","volume":"22","author":"Vaziri","year":"2009","journal-title":"Semin. Dial."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-011-0549-3","article-title":"Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression","volume":"16","author":"Vaziri","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/ki.1996.192","article-title":"Increased lipase inhibition in uremia: Identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma","volume":"49","author":"Cheung","year":"1996","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5301\/ijao.5000252","article-title":"Response of angiopoietin-like proteins 3 and 4 to hemodialysis","volume":"37","author":"Mahmood","year":"2014","journal-title":"Int. J. Artif. Organs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"150272","DOI":"10.1098\/rsob.150272","article-title":"The ANGPTL3\u20134-8 model, a molecular mechanism for triglyceride trafficking","volume":"6","author":"Zhang","year":"2016","journal-title":"Open Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E2510","DOI":"10.1210\/jc.2013-4349","article-title":"Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus","volume":"99","author":"Ebert","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0030-1267917","article-title":"Serum levels of the adipokine fasting-induced adipose factor\/angiopoietin-like protein 4 depend on renal function","volume":"43","author":"Baranowski","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00365510310000484","article-title":"Lipoprotein lipase during heparin infusion: Lower activity in hemodialysis patients","volume":"63","author":"Nasstrom","year":"2003","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mlc.2001.117666","article-title":"Lipoprotein lipase during continuous heparin infusion: Tissue stores become partially depleted","volume":"138","author":"Nasstrom","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/sdi.12380","article-title":"Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach","volume":"28","author":"Kessler","year":"2015","journal-title":"Semin. Dial."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mahmood, D., Grubbstrom, M., Lundberg, L.D., Olivecrona, G., Olivecrona, T., and Stegmayr, B.G. (2010). Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis. BMC Nephrol., 11.","DOI":"10.1186\/1471-2369-11-33"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-2143(03)00059-3","article-title":"Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme","volume":"142","author":"Nasstrom","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1525-139X.2009.00597.x","article-title":"Lipoprotein lipase disturbances induced by uremia and hemodialysis","volume":"22","author":"Stegmayr","year":"2009","journal-title":"Semin. Dial."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ndt\/gfh774","article-title":"A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing","volume":"20","author":"Nasstrom","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/ijao.5000172","article-title":"A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation","volume":"36","author":"Stegmayr","year":"2013","journal-title":"Int. J. Artif. Organs"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/ndt\/gfp017","article-title":"Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation","volume":"24","author":"Nier","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000332394","article-title":"A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies","volume":"33","author":"Brandl","year":"2012","journal-title":"Blood Purif."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ki.1997.500","article-title":"Dialytic nutrition: Provision of amino acids in dialysate during hemodialysis","volume":"52","author":"Chazot","year":"1997","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1994.339","article-title":"Amino acid and albumin losses during hemodialysis","volume":"46","author":"Ikizler","year":"1994","journal-title":"Kidney Int."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liu, Y., Xiao, X., Qin, D.P., Tan, R.S., Zhong, X.S., Zhou, D.Y., Liu, Y., Xiong, X., and Zheng, Y.Y. (2016). Comparison of Intradialytic Parenteral Nutrition with Glucose or Amino Acid Mixtures in Maintenance Hemodialysis Patients. Nutrients, 8.","DOI":"10.3390\/nu8060220"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ki.1981.57","article-title":"Protein losses during peritoneal dialysis","volume":"19","author":"Blumenkrantz","year":"1981","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.mco.0000172590.32564.b9","article-title":"Carbohydrate metabolism in uraemia","volume":"8","author":"Rigalleau","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MAT.0b013e318229aaa4","article-title":"Blunted insulinemia using high dialysate glucose concentration during hemodialysis","volume":"57","author":"Schneditz","year":"2011","journal-title":"ASAIO J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/ndt\/gfr520","article-title":"Metabolic effects of dialyzate glucose in chronic hemodialysis: Results from a prospective, randomized crossover trial","volume":"27","author":"Raimann","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nut.2015.08.001","article-title":"Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention","volume":"32","author":"Yamagishi","year":"2016","journal-title":"Nutrition"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ajcn\/31.10.1870","article-title":"The metabolic effects of hemodialysis with and without glucose in the dialysate","volume":"31","author":"Wathen","year":"1978","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ndt\/gft489","article-title":"Glycemic load is associated with oxidative stress among prevalent maintenance hemodialysis patients","volume":"29","author":"Limkunakul","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/cclm-2012-0832","article-title":"Advanced glycation end-products and skin autofluorescence in end-stage renal disease: A review","volume":"52","author":"Arsov","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"Meerwaldt","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/aor.12205","article-title":"Skin and plasma autofluorescence during hemodialysis: A pilot study","volume":"38","author":"Graaff","year":"2014","journal-title":"Artif. Organs"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5301\/ijao.5000434","article-title":"Comparing changes in plasma and skin autofluorescence in low-flux versus high-flux hemodialysis","volume":"38","author":"Ramsauer","year":"2015","journal-title":"Int. J. Artif. Organs"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ramsauer, B., Engels, G.E., Graaff, R., Sikole, A., Arsov, S., and Stegmayr, B. (2017). Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate. BMC Nephrol., 18.","DOI":"10.1186\/s12882-016-0418-0"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Haemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-012-2280-z","article-title":"Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease","volume":"28","author":"Makulska","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11255-014-0870-3","article-title":"Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis","volume":"47","author":"Siriopol","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1933","DOI":"10.1097\/MD.0000000000001933","article-title":"Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis","volume":"94","author":"Macsai","year":"2015","journal-title":"Medicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1556\/APhysiol.99.2012.2.15","article-title":"Factors influencing skin autofluorescence of patients with peritoneal dialysis","volume":"99","author":"Macsai","year":"2012","journal-title":"Acta Physiol. Hung."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000355692","article-title":"Tissue advanced glycation end product deposition after kidney transplantation","volume":"124","author":"Crowley","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1681\/ASN.2007020184","article-title":"Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: A 2-year multicenter, prospective, randomized study","volume":"18","author":"Cano","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.jrn.2009.01.019","article-title":"Oral protein supplementation alone improves anabolism in a dose-dependent manner in chronic hemodialysis patients","volume":"19","author":"Sundell","year":"2009","journal-title":"J. Ren. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ki.1994.337","article-title":"Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid","volume":"46","author":"Gutierrez","year":"1994","journal-title":"Kidney Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/014860719501900115","article-title":"Amino acid losses during hemodialysis: Effects of high-solute flux and parenteral nutrition in acute renal failure","volume":"19","author":"Hynote","year":"1995","journal-title":"J. Parenter. Enteral Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ndt\/11.supp2.108","article-title":"Protein catabolism in maintenance haemodialysis: The influence of the dialysis membrane","volume":"11","author":"Gutierrez","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3346\/jkms.2007.22.4.598","article-title":"The effect of dialysis membrane flux on amino acid loss in hemodialysis patients","volume":"22","author":"Gil","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5414\/CN107982","article-title":"Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury","volume":"81","author":"Umber","year":"2014","journal-title":"Clin. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000380965","article-title":"The past, present and future of the dialyzer","volume":"185","author":"Mineshima","year":"2015","journal-title":"Contrib. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/00365590500199319","article-title":"Elderly patients on haemodialysis have 50% less functional capacity than gender- and age-matched healthy subjects","volume":"39","author":"Sterky","year":"2005","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0272-6386(98)70131-3","article-title":"Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study","volume":"32","author":"Jones","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/089686089801800211","article-title":"Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution","volume":"18","author":"Jones","year":"1998","journal-title":"Perit. Dial. Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/2359-3997000000026","article-title":"Risk of hypoglycemia during hemodialysis in diabetic patients is related to lower pre-dialysis glycemia","volume":"59","author":"Burmeister","year":"2015","journal-title":"Arch. Endocrinol. Metab."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/548\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:37:08Z","timestamp":1760207828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/9\/6\/548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,27]]},"references-count":76,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["nu9060548"],"URL":"https:\/\/doi.org\/10.3390\/nu9060548","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,27]]}}}